文献速递胃肠动力与功能性疾病

验证对罗马IV标准进行简单修改以诊断二级医疗机构中肠易激综合征的效果

Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
PubMed 文献 · Aliment Pharmacol Ther · 2024-10-28

在单一门诊连续纳入170例疑似肠易激综合征(IBS)成人,以参考标准确认IBS,验证罗马IV标准及两种简单修改的诊断性能。罗马IV标准敏感度82.1%、特异度85.1%;将腹痛频率放宽至每月3天时敏感度90.2%、特异度85.1%,阳性似然比6.06、阴性似然比0.11,诊断性能最佳。

要点

  • 罗马IV标准诊断IBS敏感度82.1%、特异度85.1%,阳性似然比5.51、阴性似然比0.21。
  • 将腹痛频率放宽至每月3天时敏感度90.2%、特异度85.1%,阳性似然比6.06、阴性似然比0.11。
  • 罗马IV标准诊断性能良好,简单放宽腹痛频率要求可改善其性能。

核心结论

  • 罗马IV标准在诊断IBS方面表现良好,简单放宽腹痛所需频率可改善其诊断性能。

研究设计与样本

  • 在单一门诊连续收集疑似IBS成人的症状数据,采用参考标准确认IBS,计算各诊断标准的敏感度、特异度及阳性与阴性似然比(含95%CI)。
  • 共纳入170例患者,女性占76.5%,平均年龄37.9岁。

主要发现

  • 罗马IV标准诊断IBS的敏感度为82.1%,特异度为85.1%,阳性似然比5.51(95%CI 2.95-11.3),阴性似然比0.21(95%CI 0.14-0.31)。
  • 将腹痛频率放宽至每月3天时诊断性能最佳:敏感度90.2%,特异度85.1%,阳性似然比6.06(95%CI 3.25-12.2),阴性似然比0.11(95%CI 0.07-0.19)。

关键数值与推荐

  • 罗马IV标准:敏感度82.1%,特异度85.1%,阳性似然比5.51(95%CI 2.95-11.3),阴性似然比0.21(95%CI 0.14-0.31)。
  • 修改标准一:重新纳入腹部不适但腹痛和不适症状频率均保持至少每周1天。
  • 修改标准二:仅纳入腹痛但症状频率放宽至每月3天,敏感度90.2%,特异度85.1%,阳性似然比6.06(95%CI 3.25-12.2),阴性似然比0.11(95%CI 0.07-0.19)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Rome IV criteria for irritable bowel syndrome (IBS) may be too restrictive for clinical practice and research. AIMS: To validate the Rome IV criteria and study the diagnostic performance of simple modifications to them. METHODS: We collected symptom data from consecutive adults with suspected IBS seen in a single clinic. We used a reference standard to confirm IBS (presence of lower abdominal pain associated with altered stool form or frequency; no evidence of organic gastrointestinal disease after limited investigation). We applied Rome IV criteria, but also two modifications. First, we re-incorporated abdominal discomfort but kept symptom frequency required for both abdominal pain and discomfort to at least 1 day per week. Second, we included only abdominal pain but relaxed symptom frequency back to 3 days per month. We calculated sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), for each diagnostic criterion. RESULTS: We recruited 170 patients (76.5% female, mean age 37.9 years). Sensitivity and specificity of the Rome IV criteria were 82.1% and 85.1%, respectively; positive and negative LRs were 5.51 (95% CI 2.95-11.3) and 0.21 (95% CI 0.14-0.31), respectively. Modifying the criteria by relaxing the frequency of abdominal pain to 3 days per month led to the best performance [sensitivity 90.2%, specificity 85.1%, positive LR 6.06 (95% CI 3.25-12.2), and negative LR 0.11 (95% CI 0.07-0.19)]. CONCLUSIONS: The Rome IV criteria performed well in diagnosing IBS. A simple modification relaxing the required frequency of abdominal pain improved their performance.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Goodoory VC, Riggott C, Khasawneh M, et al. Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Aliment Pharmacol Ther. 2024. PMID: 39466700. doi:10.1111/apt.18363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。